Trending

Akari Therapeutics

Solomon quits as Akari CEO following credit card probe

Solomon quits as Akari CEO following credit card probe

Biotech veteran quits after less than a year in charge

X

Solomon quits as Akari CEO following credit card probe

https://pharmaphorum.com/news/solomon-quits-as-akari-ceo-following-credit-card-probe/

Akari soars ahead of read-out for Soliris rival

Akari soars ahead of read-out for Soliris rival

Investors are anticipating good news from a potential rival to Alexion’s rare disease blockbuster Soliris, with shares in

X

Akari soars ahead of read-out for Soliris rival

https://pharmaphorum.com/news/akari-soliris-rival/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com